Faircourt Asset Management Inc. Announces July Distribution
Faircourt Asset Management Inc. is the Investment Advisor for Faircourt Gold Income Corp.
This press release is not for distribution in the United States or over United States wire services.
For further information on the Faircourt Funds, please visit
www.faircourtas
s
etmgt.com
or
please contact 1-800-831-0304.
You will usually pay brokerage fees to your dealer if you purchase or sell Shares of the Fund on the CBOE Canada Exchange or other alternative Canadian trading system (an 'exchange'). If the Shares are purchased or sold on an exchange, investors may pay more than the current net asset value when buying Shares of the Fund and may receive less than the current net asset value when selling them.
There are ongoing fees and expenses associated with owning units of an investment fund. An investment fund must prepare disclosure documents that contain key information about the fund. You can find more detailed information about the fund in the public filings available at
www.sedar.com
. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Southeast Asia Casting Polyurethane Market to Surpass Valuation of US$ 308.18 Million By 2033
The Southeast Asia casting polyurethane market is defined by industrial expansion, driving demand for durable polyester-based rollers and custom elastomeric parts valued for superior load-bearing capacity and operational longevity in manufacturing, mining, and infrastructure sectors. Chicago, July 29, 2025 (GLOBE NEWSWIRE) -- The Southeast Asia casting polyurethane market was valued at US$ 158.31 million in 2024 and is expected to reach US$ 308.18 million by 2033, growing at a CAGR of 7.82% during the forecast period 2025–2033. The Southeast Asia casting polyurethane market is entering a period of unprecedented expansion, poised for significant growth throughout 2024 and 2025. This surge is not a fleeting trend but a fundamental shift, underpinned by vigorous industrialization, substantial foreign investment, and a widespread regional pivot towards high-performance, durable materials. As manufacturing capabilities across the block intensify and diversify, casting polyurethane is emerging as a critical enabling material. Download a Free Sample to Preview the Report: The heavy reliance on casting as a production method is a cornerstone of the casting polyurethane market in Southeast Asia, driven by its unparalleled cost-effectiveness and design freedom for industrial applications. This method provides a clear advantage over traditional manufacturing, particularly for custom and low-to-medium volume production. A Malaysian foundry, in its 2024 annual review, cited a 40% reduction in lead time for custom industrial parts since incorporating polyurethane casting. The process facilitates significant part consolidation and optimization; a Vietnamese agricultural machinery manufacturer, in a 2025 case study, revealed that redesigning a metal assembly into a single cast polyurethane component cut its weight by 60% and its cost by 25%. This efficiency is why specialized firms, like a Singaporean automation company, now use cast polyurethane for over 70% of their custom jigs and fixtures as of early 2025. This report provides an in-depth analysis of the key drivers, sectoral opportunities, and country-specific dynamics shaping this vibrant market, offering stakeholders meticulously researched insights to guide strategic decisions and capitalize on the burgeoning demand landscape. Key Findings in Southeast Asia Casting Polyurethane Market Market Forecast (2033) US$ 308.18 million CAGR 7.82% By Product Type Rolls (34.06%) By Prepolymer Type Polyester Based Prepolymer (43.65%) By Manufacturing Process Casting (Liquid Polyurethane) (50.38%) By Design Elastomeric (39.09%) By Application Industrial Castings (30.34%) By Distribution Channel Distributors/Wholesalers (58.46%) By Industry Automotive (26.73%) Top Drivers Rapid industrialization and manufacturing expansion are driving regional market growth. Increasing investment in infrastructure development fuels polyurethane component demand. Superior performance characteristics over traditional materials like rubber and metal. Top Trends Growing demand for high-performance polyester-based polyurethane for durable applications. Shift towards sustainable and bio-based polyurethane materials is gaining traction. Rising adoption of automation for customized industrial component production. Top Challenges High volatility in raw material prices impacts overall production costs. Intense competition from low-cost materials and fragmented local market players. Limited skilled technicians for complex and advanced polyurethane processing methods. Unprecedented Industrial Expansion Fuels Demand in the Southeast Asia Casting Polyurethane Market At the heart of this growth story is the region's dynamic economic evolution. A confluence of favorable government policies, a rapidly growing middle class, and the relocation of global supply chains is transforming Southeast Asia into a global manufacturing powerhouse. This industrial renaissance is a primary catalyst for the Southeast Asia casting polyurethane market, as industries from automotive to electronics demand materials that offer superior durability, versatility, and performance. The transition away from traditional materials towards advanced polymers like casting polyurethane is accelerating, driven by the need for efficiency, longevity, and higher quality standards in finished products. Automotive Sector Surge Creates Significant Opportunities for Casting Polyurethane Applications The regional automotive industry stands out as a principal consumer in the casting polyurethane market of the Southeast Asia, with its aggressive expansion plans directly fueling demand for cast polyurethane components like bushings, seals, and interior parts. In Thailand, the automotive hub of the region, manufacturers are projected to increase their production targets for electric vehicles by a substantial 15% in 2025, a move that requires advanced polyurethane materials for lightweighting and battery components. Vietnam's commercial vehicle production is simultaneously expected to see a 10% rise in 2024. This growth extends to the aftermarket, where Malaysia's sector is forecast to expand by 8% in 2024, increasing the need for durable cast polyurethane replacement parts. Underscoring this trend, a leading Japanese automaker has committed a $200 million investment to expand its Indonesian production facility, with a scheduled completion in 2025. Monumental Infrastructure and Construction Projects Propel Polyurethane Consumption Across the Region A massive wave of infrastructure development is sweeping across Southeast Asia, creating immense demand for construction-related polyurethane applications such as flooring, insulation, coatings, and sealants. The Philippine government has allocated an additional $5 billion for vital infrastructure projects in 2024, directly boosting the Southeast Asia casting polyurethane market. In Vietnam, the urban landscape is changing rapidly, with the construction of high-rise residential and commercial buildings expected to increase by 12% in 2025. Sustainability is also a key factor; Thailand's green building initiatives are projected to drive a 20% increase in the use of energy-efficient polyurethane insulation in 2024. Furthermore, Malaysia is strategically planning the development of three new industrial parks in 2025, which will create significant, concentrated demand for industrial-grade polyurethane flooring and sealants. Advanced Electronics Manufacturing Hubs Drive Demand for Specialized Polyurethane Formulations Southeast Asia casting polyurethane market's role in the global electronics supply chain is becoming increasingly sophisticated, fueling the need for specialized casting polyurethane for potting, encapsulation, and thermal management. Singapore continues to lead in high-value manufacturing, evidenced by a major semiconductor firm's $1 billion investment in a new fabrication plant set to be operational by 2025. Vietnam's consumer electronics production is on a sharp upward trajectory, with an anticipated growth of 15% in 2024, boosting the use of polyurethane to protect sensitive components. Concurrently, the digital economy's expansion is driving a 25% projected increase in the demand for data centers in Indonesia in 2025, a sector that requires specialized polyurethane materials for critical thermal management systems to ensure operational stability. Heavy Industries and Mining Operations Demand High-Performance Casting Polyurethane Solutions In the region's demanding heavy industrial and mining sectors, the superior abrasion and impact resistance of casting polyurethane makes it the material of choice for critical components. Indonesia's formidable mining sector, for instance, is expected to increase its output by 7% in 2024, directly driving higher demand for hard-wearing polyurethane screens, scrapers, and equipment liners that can withstand harsh operational conditions. This need for durability is also seen in maritime infrastructure. The expansion of a major port in Malaysia, a massive project valued at $500 million and due for completion in 2025, will significantly increase the requirement for robust polyurethane fenders, buoys, and wear pads, showcasing the material's critical role in large-scale industrial applications and its importance to the Southeast Asia casting polyurethane market. A Granular Country-Level Analysis of the Southeast Asia Casting Polyurethane Market A closer look at individual nations reveals distinct and compelling growth narratives. Thailand, solidifying its position as an automotive hub, aims to produce over 500,000 electric vehicles annually by 2025, while its burgeoning medical device market is projected to grow by 9% in 2024, increasing the use of biocompatible cast polyurethanes. Vietnam is a manufacturing titan, with its manufacturing PMI expected to remain strong above 52.0 throughout 2024, and its footwear export value is forecast to climb by 10% in 2025, driven by demand for polyurethane soles. Indonesia's growth is powered by its natural resources and manufacturing sectors. The country is set to increase its nickel processing capacity by 30% in 2024 and its furniture export market is expected to grow by 8% in 2025, increasing the use of polyurethane coatings and foams. In Malaysia, the oil and gas sector is planning 15 new offshore projects by the end of 2025, creating strong demand for pipeline coatings and seals. Malaysia's renewable energy sector is also expanding, aiming to add 1,200 MW of solar capacity in 2024, utilizing polyurethane in panel manufacturing. The Philippines showcases growth fueled by domestic activity; overseas worker remittances, a key driver of construction, are projected to increase by 4% in 2024, while the nation's shipbuilding and repair industry is expected to see 6% growth in 2025. This diverse country-level activity solidifies the bright prospects for the Southeast Asia casting polyurethane market. Analyzing the Crucial Raw Material and Supply Chain Dynamics for Regional Success The continued growth of the Southeast Asia casting polyurethane market is intrinsically linked to the stability and evolution of its supply chain. The availability of key raw materials, namely MDI (methylene diphenyl diisocyanate) and polyols, is a critical factor for manufacturers. In a significant development for regional supply, a new MDI production facility is expected to come online in late 2024, adding 50,000 metric tons of annual capacity and potentially easing supply constraints. From a cost perspective, industry analysts anticipate a moderate increase of 3-5% for polyol prices in the first half of 2025 due to global supply chain realignments. To support this flow of materials, regional investment in logistics and warehousing infrastructure is projected to increase by a remarkable 18% in 2024, enhancing efficiency and ensuring timely delivery across the thriving Southeast Asia market. Need a Customized Version? Request It Now: Future Outlook: Sustained Momentum for the Southeast Asia Casting Polyurethane Market The outlook for the Southeast Asia market through 2025 and beyond is exceptionally promising. The convergence of macro-economic strength targeted industrial policy, major infrastructure investment, and technological advancement creates a powerful and sustained tailwind. The 70 distinct findings presented in this analysis collectively paint a picture of a market rich with opportunity, driven by diverse and robust end-use sectors. From the electric vehicles rolling off production lines in Thailand to the new semiconductor fabs in Singapore and the expanding mines in Indonesia, casting polyurethane is the common denominator of progress and performance. Stakeholders who align their strategies with these powerful growth vectors are well-positioned to achieve remarkable success in the dynamic and rapidly expanding Southeast Asia casting polyurethane market. Southeast Asia Casting Polyurethane Market Major Players BASF SE Evonik Industries Sika AG Dow Inc. Asia Polyurethane Line Seiki Co., Ltd. Prostech Seen Joo Pte Ltd Other Prominent Players Key Segmentation: By Product Type Rolls Formwork Pads Sheets Others By Prepolymer Type Polyester Base Prepolymer Polyether Base Prepolymer Polycaprolactone Base Prepolymer Others By Resin Grade Standard Grade High-Performance Grade Specialty Grade Others By Manufacturing Process Reaction Injection Molding (RIM) Casting (Liquid Polyurethane) Extrusion Compression Molding Others By Design Rigid Flexible Foamed Elastomeric Others By Application Industrial Castings Wheels & Tires Belt & Hoses Medical Devices Footwear Components Concrete Blocks Others By Distribution Channel Direct Sales Online Sales Distributors/Wholesalers By Industry Automotive Mechanical Electronics & Instruments Aerospace & Defense Footwear & Sports Healthcare Others By Country Malaysia Indonesia Myanmar Philippines Thailand Singapore Vietnam Rest of Southeast Asia Need Strategic Clarity? Talk to Our Analyst Today: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hamilton Spectator
6 minutes ago
- Hamilton Spectator
Air Canada reports second-quarter earnings down in ‘challenging environment'
MONTREAL - Air Canada says second-quarter earnings were down from last year in what it characterized as a 'challenging environment.' Challenges include an 11 per cent drop in revenue in the airline's U.S. transborder routes that it attributed to geopolitical tensions and a lower Canadian dollar. The airline however saw increases in revenue from other areas, including its Atlantic and Latin American routes, as it redirected capacity, said chief executive Michael Rousseau in a statement. 'We have strategically redirected capacity to high-demand markets and captured demand for premium services, leveraging the breadth and strength of our global network.' Overall, the airline reported a net income of $186 million in the second quarter, down from $410 million in the same quarter last year. Air Canada says that on an adjusted basis, it had a net income of $207 million in the quarter compared with $369 million in the same quarter last year. Adjusted earnings worked out to 60 cents per diluted share in the quarter, compared to 98 cents per share last year. Analysts on average had expected an adjusted profit of 72 cents per diluted share, according to LSEG Data & Analytics. Passenger revenues in the quarter amounted to $5.03 billion, up one per cent from last year on a 2.5 per cent capacity growth. Revenue from its U.S. transborder segment was $961 million, down from $1.08 billion last year, while its Atlantic routes saw $1.64 billion in revenue, up from $1.56 billion last year. For the first six months of the year, revenue from U.S. flights were down 7.9 per cent and its Pacific routes were down 2.8 per cent, contributing to an overall drop of 0.8 per cent in passenger revenue compared with last year. Despite the challenges, the airline reaffirmed its financial guidance for the year that it issued in May. Results were slightly below expectations on higher-than-expected costs but overall fairly neutral, said RBC analyst James McGarragle in a note. 'We are taking a neutral view on the results, as the broader narrative of demand recovery and operational realignment remains intact despite the modest cost-related headwinds in the quarter.' This report by The Canadian Press was first published July 29, 2025. Companies in this story: (TSX:AC)
Yahoo
12 minutes ago
- Yahoo
AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients
BERWYN, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, highlights the value of its HUB partnership with Abeona Therapeutics Inc. (Nasdaq: ABEO) in the successful pre-and-post launch commercialization of ZEVASKYN™, an FDA-approved cell-based gene therapy. Working as a collaborative partner, AscellaHealth designed and executed patient-centric, end-to-end solutions to address unique clinical, operational and reimbursement needs for a new-to-world autologous cell-based gene therapy. By focusing on the requirements of patients throughout the entire therapeutic journey, AscellaHealth led the collaborative effort to build and launch AbeonaAssist™, a highly customized patient support program that creates a seamless experience for patients, caregivers and healthcare providers. "Abeona's groundbreaking cell-based gene therapy demanded a HUB partner who could build tailored infrastructure from the ground up,' said William White, Vice President of Market Access at Abeona Therapeutics. 'AscellaHealth's comprehensive expertise in navigating this complex journey, from patient and provider engagement to optimizing reimbursement for this first-of-its-kind treatment, made them the unequivocal partner of choice. Since launch, their unwavering commitment to a patient-centric model, which perfectly aligns with our program's vision, has proven invaluable.' Bill Oldham, Chairman and President, AscellaHealth, says, 'We value our strategic partnership with Abeona which is built upon an aligned vision, a foundation of shared goals and a clear understanding of what can be achieved through collaboration. Together, we have created synergies that not only benefit both organizations, but most importantly, patient access to treatment and optimized clinical outcomes. Abeona epitomizes our description of an ideal partner that is committed to open communications, trust and transparency.' AscellaHealth's integrated patient services and HUB model are proving instrumental in achieving optimal results for life science manufacturers launching specialty pharmaceuticals, and cell and gene therapies for individuals with complex, chronic conditions and rare disease. The results highlight enhanced compliance, retention and satisfaction rates, underscoring the effectiveness of AscellaHealth's tailored programs that consistently deliver measurable outcomes:About ZEVASKYN™ (prademagene zamikeracel) gene-modified cellular sheets ZEVASKYN is the first and only autologous cell sheet-based gene therapy for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). RDEB is a severe skin disease caused by a defect in both copies of the COL7A1 gene resulting in the inability to produce functional type VII collagen. Without functional type VII collagen and anchoring fibrils, the skin is fragile and blisters easily, leading to wounds that continually open and close, or fail to heal altogether. Patients often have large open wounds that can lead to serious life-threatening complications. ZEVASKYN incorporates the functional type VII collagen-producing COL7A1 gene into a patient's own skin cells, ex vivo, using a replication-incompetent retroviral vector to produce functional type VII collagen in treated wounds. ZEVASKYN has demonstrated clinically meaningful wound healing and pain reduction with a single surgical application. For more information, visit Indication ZEVASKYN™ (prademagene zamikeracel) is an autologous cell sheet-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). Important Safety Information Serious allergic reactions to ZEVASKYN can occur. Patients should get medical help right away if they experience symptoms like itching, swelling, hives, difficulty breathing, runny nose, watery eyes, or nausea. In rare cases, a severe reaction called anaphylaxis may happen. There is a potential risk that treatment with ZEVASKYN may contribute to the development of cancer because of how the therapy works. Patients should be monitored for the rest of their lives to check for any signs of cancer. ZEVASKYN is made using human and animal materials. Although these materials are tested before use, the risk of passing on infections cannot be eliminated. The most common side effects are pain from the procedure and itching. This is not a complete list of side effects. Patients should call their care team for medical advice about side effects. Side effects may be reported to Abeona at 1-844-888-2236 or FDA at 1-800-FDA-1088 or See full Prescribing Information. About AscellaHealth AscellaHealth is a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance the quality of life for patients with complex, chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. Visit About Abeona TherapeuticsAbeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona's ZEVASKYN™ (prademagene zamikeracel) is the first and only autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The Company's fully integrated cGMP cell and gene therapy manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. The Company's development portfolio features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. Abeona's novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases. For more information, visit ZEVASKYN™, Abeona Assist™, Abeona Therapeutics®, and their related logos are trademarks of Abeona Therapeutics Inc. Media: Caroline Chambers CPR Communicationscchambers@ x 21 A photo accompanying this announcement is available at This press release was published by a CLEAR® Verified in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
